References
- Bouvet A. Invasive infections by Streptococcus viridans (oral streptococci) excluding pneumococci. Presse Med 1997; 26: 1768–73.
- Bochud PY, Calandra T, Francioli P. Bacteremia due to viridans streptococci in neutropenic patients: a review. Am J Med 1994; 97: 256–64.
- Soto A, McWhinney PH, Kibbler CC, Cohen J. Cytokine release and mitogenic activity in the viridans streptococcal shock syndrome. Cytokine 1998; 10: 370–6.
- Marron A, Carratala J, Gonzalez-Barca E, Fernandez-Sevilla A, Alcaide F, Gudiol F. Serious complications of bacteremia caused by viridans streptococci in neutropenic patients with cancer. Clin Infect Dis 2000; 31: 1126–30.
- Carratala J, Alcaide F, Fernandez-Sevilla A, Corbella X, Linares J, Gudiol F. Bacteremia due to viridans streptococci that are highly resistant to penicillin: increase among neutropenic patients with cancer. Clin Infect Dis 1995; 20: 1169–73.
- Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 1994; 96: 200–9.
- Harris GD, Steimle J. Compiling the identifying features of bacterial endocarditis. Vague clues may point to this dangerous infection. Postgrad Med J 2000; 107: 75–6, 79–83.
- van der Meer JT, van Vianen W, Hu E, van Leeuwen WB, Valkenburg HA, Thompson J, et al. Distribution, antibiotic susceptibility and tolerance of bacterial isolates in culture-positive cases of endocarditis in The Netherlands. Eur J Clin Microbiol Infect Dis 1991; 10: 728–34.
- Douglas CW, Heath J, Hampton KK, Preston FE. Identity of viridans streptococci isolated from cases of infective endocarditis. J Med Microbiol 1993; 39: 179–82.
- Douglas CW, Brown PR, Preston FE. Platelet aggregation by oral streptococci. FEMS Microbiol Lett 1990; 60: 63–7.
- Herzberg MC. Platelet-streptococcal interactions in endocarditis. Crit Rev Oral Biol Med 1996; 7: 222–36.
- Wisplinghoff H, Reinert RR, Cornely O, Seifert H. Molecular relationships and antimicrobial susceptibilities of viridans group streptococci isolated from blood of neutropenic cancer patients. J Clin Microbiol 1999; 37: 1876–80.
- Kerr KG, Armitage HT, McWhinney PH. Activity of quinolones against viridans group streptococci isolated from blood cultures of patients with haematological malignancy. Support Care Cancer 1999; 7: 28–30.
- de Azavedo JC, Trpeski L, Pong-Porter S, Matsumura S, Low DE. In vitro activities of fluoroquinolones against antibiotic- resistant blood culture isolates of viridans group streptococci from across Canada. Antimicrob Agents Chemother 1999; 43: 2299–301.
- Rosser SJ, Alfa MJ, Hoban S, Kennedy J, Harding GK. E test versus agar dilution for antimicrobial susceptibility testing of viridans group streptococci. J Clin Microbiol 1999; 37: 26–30.
- Netzer RO, Zollinger E, Seiler C, Cerny A. Infective endocarditis: clinical spectrum, presentation and outcome. An analysis of 212 cases 1980–1995. Heart 2000; 84: 25–30.